KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Aquestive Therapeutics (AQST) Long-Term Debt Issuances (2019 - 2020)

Aquestive Therapeutics (AQST) has 1 years of Long-Term Debt Issuances data on record, last reported at $50.0 million in Q4 2020.

  • For Q4 2020, Long-Term Debt Issuances changed N/A year-over-year to $50.0 million; the TTM value through Dec 2020 reached $50.0 million, changed N/A, while the annual FY2023 figure was $31.1 million, N/A changed from the prior year.
  • Long-Term Debt Issuances reached $50.0 million in Q4 2020 per AQST's latest filing.
  • Across five years, Long-Term Debt Issuances topped out at $50.0 million in Q4 2020 and bottomed at $50.0 million in Q4 2020.